✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Strides Pharma Science Ltd.

STAR

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹8,728 Cr.
P/E
21.97

Strides Pharma Science Ltd.

  • Strides Pharma Scien
  • Marksans Pharma
  • Procter&Gamble Healt
  • TJI Pharma - Small Cap

FAQs on Strides Pharma Science Ltd. Shareprice

Strides Pharma Scien has given lower returns compared to its competitors.
Strides Pharma Scien has grown at ~2.3% over the last 8yrs while peers have grown at a median rate of 18.16%

Strides Pharma Scien is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Strides Pharma Scien is 21.97, while 3 year average PE is 6.87.
Also latest EV/EBITDA of Strides Pharma Scien is 11.77 while 3yr average is 21.71.

View FAQ's On Business

Growth Table

  • Strides Pharma Science Ltd.
  • Marksans Pharma
  • Procter&Gamble Healt

Balance Sheet

  • Strides Pharma Science Ltd.
  • Marksans Pharma
  • Procter&Gamble Healt

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Strides Pharma Science Ltd.
  • Marksans Pharma
  • Procter&Gamble Healt

Cash Flow

  • Strides Pharma Science Ltd.
  • Marksans Pharma
  • Procter&Gamble Healt

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Strides Pharma Science Ltd.
  • Marksans Pharma
  • Procter&Gamble Healt

Quarterly Results

  • Strides Pharma Science Ltd.
  • Marksans Pharma
  • Procter&Gamble Healt

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Strides Pharma Science Ltd. Financials

Balance sheet of Strides Pharma Scien is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Strides Pharma Scien is increasing.
Latest net debt of Strides Pharma Scien is ₹1,606 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹1,538 Crs.

The profit is oscillating.
The profit of Strides Pharma Scien is ₹410 Crs for TTM, ₹3,593 Crs for Mar 2025 and -₹70.61 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Strides Pharma Scien latest dividend payout ratio is 1.03% and 3yr average dividend payout ratio is 1.03%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech